People on the Move Archives - Page 41 of 155

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

Study Maps Microplastics Throughout the Body, Revealing Organ-Level Effects

April 28, 2026

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

April 29, 2026

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

April 28, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Komodo Health Names Paul Thomas Chief Financial Officer

Strand Therapeutics Names Kunal Bhatia Chief Financial Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

Most Read

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Study Maps Microplastics Throughout the Body, Revealing Organ-Level Effects

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

POPULAR CATEGORY

ABOUT US

FOLLOW US